Posts
Revolutionary Drug Discovery with Artificial Intelligence
Explore the role of AI in Drug Discovery. It has the potential to dramatically speed up the process of finding new medications, leading to faster development of more effective treatments with fewer side effects. In this article, how AI can be used to analyze large data sets to identify promising drug targets. This is a critical step in the drug discovery process, and AI can help to identify targets that would be missed by traditional methods. Overall, artificial intelligence is a powerful tool that has the potential to revolutionize the pharmaceutical industry. Learn how AI empowers drug discovery, be sure to check out the full blog post and the course offered by CliniLaunch. Visit the blog post https://clinilaunchresearch.in/ai-drug-discovery/ Share your thoughts on the potential of AI in the pharmaceutical industry. For more details about the course: Click the link below: https://clinilaunchresearch.in/best-ai-and-ml-in-healthcare-training-institute-in-india/ Contact: +91-8904269998 | contact@clinilaunchresearch.in
Join India's Largest Placement Conclave!
📅 Dates: 5th to 7th July 2024 📍 Location: Hitex Exhibition Center, Hyderabad ✨ Calling all graduates from Pharmaceutical Sciences! ✨ Register now for the Placement Conclave and seize the opportunity to learn, explore, and jumpstart your career! 🚀 Why Attend? ✅ Engage with industry leaders ✅ Explore career opportunities ✅ Network with peers and professionals ✅ Gain insights into the latest trends in pharmaceutical sciences 📲 To register, scan the QR code or click on the link below. 🔗Registration Link: https://forms.gle/z3tZdvskJvK47RL66 (copy the link and paste it on Google Chrome) 🌐 From Clinilaunch Research Institute:- Shweta, Hrishikesh, Vamshi Krishna will be there for you to help. #IndianPharmaceuticalCongress #PharmaCareers #PlacementConclave #PharmaceuticalSciences #CareerOpportunities #PharmaStudents #Networking #IndustryTrends Regards, Placement Department.
We Can Make Your Future Better.
About The Company: Lupin Digital Health Lupin Digital Health was established with a singular focus on resetting healthcare benchmarks through Digital Therapeutics (DTx). It is a fully owned subsidiary of Lupin. We are committed to improving patients' health outcomes by using technology to provide care at all times. Through scientific evidence and Machine Learning, we are developing an ecosystem that improves the health and happiness of users with chronic conditions. Our holistic care program brings together connected devices, user-friendly apps, and dedicated experts. Through these interventions, we lower the risks of subsequent issues and avoid re-hospitalization. Website: https://lupindigitalhealth.com/ Job Type: Private Hiring For: Lupin Digital Health Job Role: Clinical Research Coordinator Industry: Hospitals and Health Care Job Priority: Normal Job Nature: Office Job Position: Full time Job Location: Kalina, Mumbai Work Mode: Work from office Salary Range: 20,000/- + 6,000/- Expenses = Total 26,000/- Per month Experience Range: Freshers Date Published: 28-06-2024 Valid Through: 29-06-2024 ( 11:00 AM ) Responsibilities: 1. Coordinating clinical studies 2. Patient Callings regarding program feedback 3. COE for all marketing related materials Qualification: MBBS, BHMS, BAMS, BDS Application Link: https://forms.gle/WrCvT63kERBKfHLq7 (Copy the link ad paste it on google chrome and fill the application) Placement Undertaking form - Placement Undertaking Form - Lupin Digital Health.docx (kindly download the form and upload) All interested students are required to upload their resume in PDF format and rename it as "Company Name Full Name” Eg. ( Lupin Digital Health ) In case of any relevant queries, feel free to contact Shweta ( 9958282532 ) Vamshi Krishna ( 9391161720 ) for queries. The deadline to fill out the Google Form and upload the resume before 29-06-2024 at 11:00 AM. Kindly take note of the deadline as no applications will be accepted after it. Regards, Placement Department
Hypertension
Risk factors Modifiable risk factors include unhealthy diets (excessive salt consumption, a diet high in saturated fat and trans fats, low intake of fruits and vegetables), physical inactivity, consumption of tobacco and alcohol, and being overweight or obese. In addition, there are environmental risk factors for hypertension and associated diseases, where air pollution is the most significant. Non-modifiable risk factors include a family history of hypertension, age over 65 years and co-existing diseases such as diabetes or kidney disease. Symptoms Most people with hypertension don’t feel any symptoms. Very high blood pressures can cause headaches, blurred vision, chest pain and other symptoms. Checking your blood pressure is the best way to know if you have high blood pressure. If hypertension isn’t treated, it can cause other health conditions like kidney disease, heart disease and stroke. People with very high blood pressure (usually 180/120 or higher) can experience symptoms including: severe headaches chest pain dizziness difficulty breathing nausea vomiting blurred vision or other vision changes anxiety confusion buzzing in the ears nosebleeds abnormal heart rhythm If you are experiencing any of these symptoms and a high blood pressure, seek care immediately. The only way to detect hypertension is to have a health professional measure blood pressure. Having blood pressure measured is quick and painless. Although individuals can measure their own blood pressure using automated devices, an evaluation by a health professional is important for assessment of risk and associated conditions. Treatment Lifestyle changes can help lower high blood pressure. These include: eating a healthy, low-salt diet losing weight being physically active quitting tobacco. If you have high blood pressure, your doctor may recommend one or more medicines. Your recommended blood pressure goal may depend on what other health conditions you have. Blood pressure goal is less than 130/80 if you have: cardiovascular disease (heart disease or stroke) diabetes (high blood sugar) chronic kidney disease high risk for cardiovascular disease. For most people, the goal is to have a blood pressure less than 140/90. There are several common blood pressure medicines: ACE inhibitors including enalapril and lisinopril relax blood vessels and prevent kidney damage. Angiotensin-2 receptor blockers (ARBs) including losartan and telmisartan relax blood vessels and prevent kidney damage. Calcium channel blockers including amlodipine and felodipine relax blood vessels. Diuretics including hydrochlorothiazide and chlorthalidone eliminate extra water from the body, lowering blood pressure. Prevention Lifestyle changes can help lower high blood pressure and can help anyone with hypertension. Many who make these changes will still need to take medicine. These lifestyle changes can help prevent and lower high blood pressure. Do: Eat more vegetables and fruits. Sit less. Be more physically active, which can include walking, running, swimming, dancing or activities that build strength, like lifting weights. Get at least 150 minutes per week of moderate-intensity aerobic activity or 75 minutes per week of vigorous aerobic activity. Do strength building exercises 2 or more days each week. Lose weight if you’re overweight or obese. Take medicines as prescribed by your health care professional. Keep appointments with your health care professional. Don’t: eat too much salty food (try to stay under 2 grams per day) eat foods high in saturated or trans fats smoke or use tobacco drink too much alcohol (1 drink daily max for women, 2 for men) miss or share medication. Reducing hypertension prevents heart attack, stroke and kidney damage, as well as other health problems. Reduce the risks of hypertension by: reducing and managing stress regularly checking blood pressure treating high blood pressure managing other medical conditions reducing exposure to polluted air. Complications of uncontrolled hypertension Among other complications, hypertension can cause serious damage to the heart. Excessive pressure can harden arteries, decreasing the flow of blood and oxygen to the heart. This elevated pressure and reduced blood flow can cause: chest pain, also called angina; heart attack, which occurs when the blood supply to the heart is blocked and heart muscle cells die from lack of oxygen. The longer the blood flow is blocked, the greater the damage to the heart; heart failure, which occurs when the heart cannot pump enough blood and oxygen to other vital body organs; and irregular heart beat which can lead to a sudden death. Hypertension can also burst or block arteries that supply blood and oxygen to the brain, causing a stroke. In addition, hypertension can cause kidney damage, leading to kidney failure. Hypertension in low- and middle-income countries The prevalence of hypertension varies across regions and country income groups. The WHO African Region has the highest prevalence of hypertension (27%) while the WHO Region of the Americas has the lowest prevalence of hypertension (18%). The number of adults with hypertension increased from 594 million in 1975 to 1.13 billion in 2015, with the increase seen largely in low- and middle-income countries. This increase is due mainly to a rise in hypertension risk factors in those populations. WHO response The World Health Organization (WHO) supports countries to reduce hypertension as a public health problem. In 2021, WHO released a new guideline for on the pharmacological treatment of hypertension in adults. The publication provides evidence-based recommendations for the initiation of treatment of hypertension, and recommended intervals for follow-up. The document also includes target blood pressure to be achieved for control, and information on who, in the health-care system, can initiate treatment. To support governments in strengthening the prevention and control of cardiovascular disease, WHO and the United States Centers for Disease Control and Prevention (U.S. CDC) launched the Global Hearts Initiative in September 2016, which includes the HEARTS technical package. The six modules of the HEARTS technical package (Healthy-lifestyle counselling, Evidence-based treatment protocols, Access to essential medicines and technology, Risk-based management, Team-based care, and Systems for monitoring) provide a strategic approach to improve cardiovascular health in countries across the world. In September 2017, WHO began a partnership with Resolve to Save Lives, an initiative of Vital Strategies, to support national governments to implement the Global Hearts Initiative. Other partners contributing to the Global Hearts Initiative are the CDC Foundation, the Global Health Advocacy Incubator, the Johns Hopkins Bloomberg School of Public Health, the Pan American Health Organization (PAHO) and the U.S. CDC. Since implementation of the programme in 2017 in 31 countries low- and middle-income countries, 7.5 million people have been put on protocol-based hypertension treatment through person-centred models of care. These programmes demonstrate the feasibility and effectiveness of standardized hypertension control programmes.